Class II
Terminated
NEOGEN-D (Dextromethorphan HBr, 30 mg; Guaifenesin, 200 mg; Phenylephrine HCl, 7.5 mg) in each 5 mL tsp, Raspberry Flavor, 16 fl oz (473 mL) bottle, Manufactured in the USA for Kramer Novis, San Juan,…
Why: CGMP Deviations: products were manufactured with lack of process validation, cleaning validation, stability studies, and other current good manufacturing practice violations.
- Company
- Pharma-Natural Inc.
Miami Lakes, FL, United States - Reported
- Jul 31, 2019
- Recall started
- Jun 21, 2019
- Ended
- Oct 27, 2021
- Where sold
- Consignees in FL and TX who may have further distributed Nationwide in the USA and Puerto Rico.
- Amount
- 2052 bottles
- Full product description
- NEOGEN-D (Dextromethorphan HBr, 30 mg; Guaifenesin, 200 mg; Phenylephrine HCl, 7.5 mg) in each 5 mL tsp, Raspberry Flavor, 16 fl oz (473 mL) bottle, Manufactured in the USA for Kramer Novis, San Juan, PR 00917, NDC 52083-699-16.
- Lots / codes affected
- All lots remaining within expiry.
Class I: could cause serious harm or death. Class II: could cause temporary or treatable problems. Class III: unlikely to cause harm.